Literature DB >> 31301223

Postoperative pulmonary complications in contemporary cohort of patients with pulmonary hypertension.

S Chandralekha Kruthiventi1, Garvan C Kane, Juraj Sprung, Toby N Weingarten, Mary Ellen Warner.   

Abstract

Patients with pulmonary hypertension are at increased risk for postoperative pulmonary complications (PPCs). Herein, we review PPCs in pulmonary hypertension patients undergoing non-cardiac procedures under general anesthesia. The medical records of pulmonary hypertension patients who underwent surgery with general anesthesia between 2010 and 2017 were reviewed for PPCs. In addition we reviewed nursing-documented respiratory depressive episodes in the post-anesthesia care unit to assess the associations between these episodes and later PPCs. There were 20 PPCs among 128 patients who underwent 197 procedures (10.2 per 100 surgeries) [95% CI 6.7-15.2]. Of these, 5 occurred during anesthesia recovery and 15 following anesthesia recovery. Three-quarters of the PPCs occurred within 24 postoperative hours. All the PPCs were severe. The frequency of PPCs was significantly higher in those who experienced respiratory depression during anesthesia recovery vs. in those who did not (5/17, 29% vs. 10/175, 6%; odds ratio 5.15, 95% CI 1.58-16.81, p = 0.007). Increased PPC rates were observed among patients who were current/previous smokers and who routinely use benzodiazepines, and among those undergoing emergent surgery. With treatment, all PPCs resolved. The rate of PPCs in the population of contemporary surgical pulmonary hypertension patients was 10.2%, and three-quarters occurred during first 24 postoperative hours. Patients who had respiratory depression during anesthesia recovery were 5-fold more likely to experience later PPCs.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31301223      PMCID: PMC6868488          DOI: 10.17305/bjbms.2019.4332

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  29 in total

Review 1.  Updated clinical classification of pulmonary hypertension.

Authors:  Gerald Simonneau; Michael A Gatzoulis; Ian Adatia; David Celermajer; Chris Denton; Ardeschir Ghofrani; Miguel Angel Gomez Sanchez; R Krishna Kumar; Michael Landzberg; Roberto F Machado; Horst Olschewski; Ivan M Robbins; Rogiero Souza
Journal:  J Am Coll Cardiol       Date:  2013-12-24       Impact factor: 24.094

2.  The effect of renal dysfunction on BNP, NT-proBNP, and their ratio.

Authors:  Pornpen Srisawasdi; Somlak Vanavanan; Charaslak Charoenpanichkit; Martin H Kroll
Journal:  Am J Clin Pathol       Date:  2010-01       Impact factor: 2.493

3.  Selexipag for the Treatment of Pulmonary Arterial Hypertension.

Authors:  Olivier Sitbon; Richard Channick; Kelly M Chin; Aline Frey; Sean Gaine; Nazzareno Galiè; Hossein-Ardeschir Ghofrani; Marius M Hoeper; Irene M Lang; Ralph Preiss; Lewis J Rubin; Lilla Di Scala; Victor Tapson; Igor Adzerikho; Jinming Liu; Olga Moiseeva; Xiaofeng Zeng; Gérald Simonneau; Vallerie V McLaughlin
Journal:  N Engl J Med       Date:  2015-12-24       Impact factor: 91.245

4.  Pulmonary hypertension: an important predictor of outcomes in patients undergoing non-cardiac surgery.

Authors:  Roop Kaw; Vinay Pasupuleti; Abhishek Deshpande; Tarek Hamieh; Esteban Walker; Omar A Minai
Journal:  Respir Med       Date:  2010-12-31       Impact factor: 3.415

5.  Primary pulmonary hypertension and coronary artery bypass surgery.

Authors:  E Kuralay; U Demírkiliç; B S Oz; F Cíngöz; H Tatar
Journal:  J Card Surg       Date:  2002 Jan-Feb       Impact factor: 1.620

6.  Intraoperative hemodynamic predictors of mortality, stroke, and myocardial infarction after coronary artery bypass surgery.

Authors:  D L Reich; C A Bodian; M Krol; M Kuroda; T Osinski; D M Thys
Journal:  Anesth Analg       Date:  1999-10       Impact factor: 5.108

7.  Pulmonary hypertension.

Authors:  Sanjiv J Shah
Journal:  JAMA       Date:  2012-10-03       Impact factor: 56.272

8.  Severe pulmonary hypertension complicates postoperative outcome of non-cardiac surgery.

Authors:  H-C Lai; H-C Lai; K-Y Wang; W-L Lee; C-T Ting; T-J Liu
Journal:  Br J Anaesth       Date:  2007-06-18       Impact factor: 9.166

9.  Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial.

Authors:  Franz Hartmann; Milton Packer; Andrew J S Coats; Michael B Fowler; Henry Krum; Paul Mohacsi; Jean L Rouleau; Michal Tendera; Alain Castaigne; Stefan D Anker; Ildiko Amann-Zalan; Silke Hoersch; Hugo A Katus
Journal:  Circulation       Date:  2004-09-20       Impact factor: 29.690

10.  Retrospective analysis of the results of liver transplantation for adults with severe hepatopulmonary syndrome.

Authors:  Eric A Collisson; Hamid Nourmand; Mark H Fraiman; Christopher B Cooper; Paul E Bellamy; Douglas G Farmer; John M Vierling; Rafik M Ghobrial; Ronald W Busuttil
Journal:  Liver Transpl       Date:  2002-10       Impact factor: 5.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.